QC
AGL icon

Quent Capital’s Agilon Health AGL Stock Holding History

Quent Capital’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-83
Closed -$2.14K – 1570
2025
Q3 		$2.14K Buy
+83
New +$3.14K ﹤0.01% 1253
2025
Q2 		– Hold
0
– -$9 – 305
2025
Q1 		– Hold
0
– – – 1316
2024
Q4 		– Sell
-19
Closed -$1.15K – 1335
2024
Q3 		$1.84K Hold
19
– – ﹤0.01% 1230
2024
Q2 		$3.06K Buy
19
+17
+850% +$2.42K ﹤0.01% 1165
2024
Q1 		$250 Hold
2
– – ﹤0.01% 1329
2023
Q4 		$515 Sell
2
-1
-33% -$362 ﹤0.01% 1286
2023
Q3 		$1.28K Buy
3
+1
+50% +$452 ﹤0.01% 1224
2023
Q2 		$676 Hold
2
– – ﹤0.01% 1259
2023
Q1 		$926 Buy
+2
New +$1.12K ﹤0.01% 1245

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Quent Capital's AGL Position: Q4 2025 in Review

Quent Capital sold out of Agilon Health (AGL) in Q4 2025, closing a stake of 83 shares — an estimated $2.14K sold.

Quent Capital first reported a position in AGL in Q1 2023 and held it in 8 quarters. The position peaked at $3.06K in Q2 2024. 194 funds tracked by Wall St. Rank hold AGL as of Q4 2025.

  • Quent Capital reported no remaining Agilon Health position as of Q4 2025 after selling out during the quarter.
  • Quent Capital sold 83 Agilon Health shares in Q4 2025, an estimated $2.14K.
  • Quent Capital first reported a position in Agilon Health in Q1 2023 and held it in 8 quarters.
  • Quent Capital's Agilon Health position peaked at $3.06K in Q2 2024.
  • 194 funds tracked by Wall St. Rank held Agilon Health as of Q4 2025.

Based on Quent Capital's 13F filing for Q4 2025, filed 29 Jan 2026.